Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 6, 2024
Product Development
Solid tumor immunotherapies headline ASCO’s first-in-human studies
A focus on first-in-class innovation and solid tumor applications
BioCentury | Apr 21, 2023
Product Development
ADC advances at AACR: target diversity, optimizing internalization
BioCentury’s analysis of the AACR 2023 abstracts highlights innovation in antibody-drug conjugate design
BioCentury | Apr 8, 2022
Discovery & Translation
Young companies taking on checkpoint inhibitor resistance at AACR22
Ten companies you may not have heard of tackling checkpoint resistance at AACR22
BioCentury | Mar 25, 2022
Discovery & Translation
AACR22 tackles the CAR T solid tumor challenge
Dual-targeting CARs, new targets and bispecific adaptors among the top innovations
BioCentury | Oct 1, 2021
Distillery Therapeutics
Inhibiting ICAM-1 to block breast cancer lung metastases
BioCentury | Nov 11, 2020
Emerging Company Profile
CatalYm: opening up tumors to immune cells
Emerging Company Profile: German start-up targets GDF15’s immunosuppressant function to enable immune cell infiltration to tumors
BioCentury | Aug 29, 2019
Distillery Therapeutics
Tumor-targeted nanoparticle delivery of gene editing therapy for breast cancer
BioCentury | Aug 28, 2019
Translation in Brief
Nanoparticles targeting CRISPR to cancer
Boston Children’s team’s system targets gene editing therapies to triple negative breast cancer cells
Items per page:
1 - 10 of 130